alzndem.png

"APOE ε4, the door to insulin-resistant dyslipidemia and brain fog?"

By S. Stoykovich & Dr. Kelly J. Gibas

Published in Alzheimers & Dementia: Diagnosis, Assessment & Disease Monitoring. 2019;11:264-269. doi:10.1016/j.dadm.2019.01.009. PMID: 30923733

(March 2019)

logo-elsevier.jpg

"Ketogenic diets may reverse Type II diabetes and ameliorate clinical depression: A case study."

By N. Cox, S. Gibas, S. Salisbury, J. Gomer, & Dr. Kelly J. Gibas

Published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019. doi:10.1016/j.dsx.2019.01.055. PMID: 31336509

(March 2019)

logo-elsevier.jpg

"Ketogenic diet rescues cognition in ApoE4 patient with mild Alzheimers disease"

By S.J. Morrill & Dr. Kelly J. Gibas

Published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(2):1187-1191. doi:10.1016/j.dsx.2019.01.035. PMID: 31336463

(April 2019)

Gibas, KJ.  Photobiomodulation & ketogenic diet for treatment of mid-periphery retinal disorders (diabetic retinopathy, dry AMD and hard drusen formation) for Alzheimer’s disease prevention.Randomized clinical trial (2019): NCT03859245 https://clinicaltrials.gov/ct2/show/NCT03859245

Gibas, K. & Stoykovich, S. (April, 2019). ApoE4, the door to insulin-resistant dyslipidemia and brain fog? A case study.Poster presentation at American Diabetes Association/WCITD – 2019 New York, NY. https://cmoffice.kenes.com/cmsearchableprogrammeV15/conferencemanager/programme/personid/anonymous/WCITD19/normal/b833d15f547f3cf698a5e922754684fa334885ed#!abstractdetails/0000394330

Gibas K.J. (2019). Dietary Ketosis a Metabolic Sister to Calorie Restriction (CR): Fatty acids activate AMPK energy circuits modulating global methylation via the SAM/SAH axis. Randomized clinical trial (2019): NCT0331917  https://clinicaltrials.gov/ct2/show/NCT03319173

Gibas K.J. (2018). Commentary: The Starving Brain: Overfed meets undernourished in the  pathology of mild cognitive impairment (MCI) and Alzheimer’s disease (AD). J Immunological Sci. (2018); 2(2): 1-3.

Gibas KJ, Halikas (2018). A. AMPK induced memory improvements in the diabetic population: A Case Study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018. doi:10.1016/j.dsx.2018.04.033. PMID: 29748034

Brown D, Gibas KJ. (2018). Metabolic syndrome marks early risk for cognitive decline with APOE4 gene variation: A case study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018. doi:10.1016/j.dsx.2018.04.030. PMID: 29706312

Dahlgren K, Gibas KJ. (2018). Ketogenic diet, high intensity interval training (HIIT) and memory training in the treatment of mild cognitive impairment: A case study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018. doi:10.1016/j.dsx.2018.04.031. PMID: 29678606

Gibas, K. (December 2018). Mouth breather? Enduring patterns of hypocapnia induce cerebral hypoxia and consequential cognitive impairments mediated by aberrant HIF-1 survival signals common to the cell danger response. Poster presentation at Cell Symposia: Metabolites as Signaling Molecules Conference, 2018, Seattle, WA. http://www.cell-symposia.com/metabolites-2018/conference-program.asp

M.K Gibas, K.J. Gibas, (2017). Induced and controlled dietary ketosis as a regulator of obesity and metabolic syndrome pathologies, Diab Met Syndr: Clin Res Rev (2017), http://dx.doi.org/10.1016/j.dsx.2017.03.022  (RCT, March 2017) PMID:28433617. https://clinicaltrials.gov/ct2/show/NCT03047447, https://www.nia.nih.gov/alzheimers/clinical-trials/dietary-ketosis-memory-loss-and-mci

Gibas, K. (November 2017). Dietary Ketosis a Metabolic Sister to Calorie Restriction (CR): Fatty acids activate AMPK energy circuits modulating global methylation via the SAM/SAH axis in mild cognitive impairment (MCI). Poster presentation at Cell Symposia: Big Ideas in Neuroscience Conference, 2017, Arlington, VA. http://www.cell-symposia.com/big-questions-in-neuroscience-2017/conference-program.asp

Gibas, K.J (2017). The Starving Brain: Overfed meets undernourished in the pathology of mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Neurochemistry International, https://doi.org/10.1016/j.neuint.2017.09.004. PMID: 28899812

Gibas, K.J. (Oct. 2017). The Retrograde Signal: Glucose Dependency Marks the Cancerous Phenotype.  Austin Diabetes Research and Austin Journal of Nutrition & Metabolism. 2017; 4(2): 1051.

Gibas, K.J. (2017). The Retrograde Signal: Glucose dependency marks the cancerous phenotype. Austin Diabetes Research, Austin Diabetes Res. 2017; 1(1): 1065.

journal-of-immunological-sciences-indeximage.png

“The Starving Brain: Overfed meets undernourished in the pathology of mild cognitive impairment (MCI) and Alzheimer’s disease (AD)”

By Dr. Kelly J. Gibas

Published in Journal of Immunological Sciences